Haptoglobin enhances cardiac transplant rejection

Area of Science:

• Immunology
• Transplantation Biology
• Molecular Medicine

Background:

• Early graft inflammation significantly impacts acute and chronic rejection in heart transplantation.
• The precise initiation mechanisms of this early inflammation remain incompletely understood.

Purpose of the Study:

• To identify key inflammatory modulators following cardiac transplantation.
• To elucidate the underlying molecular mechanisms of these modulators in graft inflammation.

Main Methods:

• Utilized a murine heterotopic cardiac transplant model.
• Employed unbiased mass spectrometric analysis to identify upregulated proteins in early post-transplant cardiac tissue.
• Investigated the role of haptoglobin using haptoglobin-deficient mice and CTLA4 immunoglobulin treatment.

Main Results:

• Haptoglobin was significantly upregulated in cardiac grafts within 72 hours post-transplantation.
• Haptoglobin-deficient recipients treated with CTLA4 immunoglobulin showed >100-day allograft survival, unlike wild-type recipients.
• Haptoglobin was found to increase pro-inflammatory cytokines (interleukin-6, macrophage inflammatory protein-2) and decrease anti-inflammatory cytokine (interleukin-10), promoting dendritic cell recruitment and T-cell responses.
• Haptoglobin presence was confirmed in human cardiac allografts experiencing acute rejection.

Conclusions:

• Haptoglobin acts as an enhancer of inflammation in cardiac transplantation, contrasting its known antioxidant function in vascular inflammation.
• Haptoglobin may play a crucial role in the inflammatory processes of other sterile inflammatory conditions.
• Targeting haptoglobin presents a potential therapeutic strategy for improving cardiac allograft outcomes.